University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

Hobart Harris, M.P.H., M.D.

Gastrointestinal surgeon

Dr. Hobart W. Harris, chief of General Surgery at UCSF Medical Center, is an expert in treating surgical infections and diseases of the pancreas and biliary system. He treats patients with complicated and often life-threatening conditions in the Complex Abdominal Surgery Program. His areas of expertise include pancreas and bile duct cancer, acute and chronic pancreatitis, islet cell transplantation for pancreatitis, gallstone disease, intra-abdominal sepsis and serious infections of the skin and soft tissue.

Harris earned undergraduate, medical and public health degrees at Harvard University, then completed an internship and residency in surgery at UCSF. After residency training, he completed a fellowship in heptobiliary surgery at the University of Hong Kong, Queen Mary Hospital and joined UCSF in 1994. Harris is a fellow of the American College of Surgeons and is a member of numerous surgical and scientific societies including the American Surgical Association. His research focuses on surgical infections, innate immunity and inflammatory diseases of the pancreas.

Clinics

Center for the Study of Gastrointestinal Motility and Secretion
400 Parnassus Ave., Box 0310
San Francisco, CA 94143-0310
Phone: (415) 353-9383
Fax: (415) 353-2505

Gastrointestinal Surgery at Parnassus
400 Parnassus Ave., Sixth Floor
San Francisco, CA 94143-0388
Phone: (415) 353-2161
Fax: (415) 353-2505

Hours: Monday to Friday
8 a.m. – 4:30 p.m.

Pancreas Center
1600 Divisadero St., Fourth Floor
San Francisco, CA 94143-1705
Phone (Pancreatic Cancer): (415) 353-9888
Fax: (415) 353-9931

Hours: Monday to Friday
8 a.m. — 5 p.m.

Conditions & Treatments

More about Hobart Harris

Additional Languages

Spanish

Education

Harvard University School of Medicine 1983

Residencies

UCSF Medical Center, General Surgery 1993

Fellowships

University of Hong Kong, Heptobiliary Surgery 1994

Selected Research and Publications

  1. Harris HW. Clinical outcomes of biologic mesh: where do we stand? Surg Clin North Am. 2013 Oct; 93(5):1217-25.
  2. Harris HW. Biologic mesh for ventral hernia repair: a cautionary tale. Ann Surg. 2013 Jun; 257(6):997-8.
  3. Beard JH, Oresanya LB, Ohene-Yeboah M, Dicker RA, Harris HW. Characterizing the global burden of surgical disease: a method to estimate inguinal hernia epidemiology in Ghana. World J Surg. 2013 Mar; 37(3):498-503.
  4. Primus FE, Harris HW. A critical review of biologic mesh use in ventral hernia repairs under contaminated conditions. Hernia. 2013 Feb; 17(1):21-30.
  5. Harris H. Systematic review of total pancreatectomy and islet autotransplantation for chronic pancreatitis (Br J Surg 2012; 99: 761-766). Br J Surg. 2012 Jun; 99(6):767.
  6. Chuang KI, Corley D, Postlethwaite DA, Merchant M, Harris HW. Does increased experience with laparoscopic cholecystectomy yield more complex bile duct injuries? Am J Surg. 2012 Apr; 203(4):480-7.
  7. Chuang KI, Leung B, Hsu N, Harris HW. Heparin protects against septic mortality via apoE-antagonism. Am J Surg. 2011 Sep; 202(3):325-35.
  8. Leung B, Harris HW. NKT cells: the culprits of sepsis? J Surg Res. 2011 May 1; 167(1):87-95.
  9. Leung B, Harris HW. NKT cells in sepsis. Clin Dev Immunol. 2010; 2010.
  10. Spitzer AL, Chuang KI, Victorino GP, Kasravi B, Curran B, Lee D, Harris HW. Chylomicrons combined with endotoxin moderate microvascular permeability. Innate Immun. 2011 Feb; 17(3):283-92.
  11. Chuang K, Elford EL, Tseng J, Leung B, Harris HW. An expanding role for apolipoprotein E in sepsis and inflammation. Am J Surg. 2010 Sep; 200(3):391-7.
  12. Rogers SJ, Cello JP, Horn JK, Siperstein AE, Schecter WP, Campbell AR, Mackersie RC, Rodas A, Kreuwel HT, Harris HW. Prospective randomized trial of LC+LCBDE vs ERCP/S+LC for common bile duct stone disease. Arch Surg. 2010 Jan; 145(1):28-33.
  13. Mohebali K, Young DM, Hansen SL, Shawo A, Freise CE, Chang DS, Maa J, Harris HW. Open incisional hernia repair at an academic tertiary care medical center. Arch Surg. 2009 Sep; 144(9):848-52.
  14. Schecter WP, Hirshberg A, Chang DS, Harris HW, Napolitano LM, Wexner SD, Dudrick SJ. Enteric fistulas: principles of management. J Am Coll Surg. 2009 Oct; 209(4):484-91.
  15. Jamshidi R, Hill A, Harris H. Anaphylaxis caused by recurrent hydatid disease. Surg Infect (Larchmt). 2009 Apr; 10(2):155-7.
  16. Mukhtar RA, Kattan OM, Harris HW. Variation in annual volume at a university hospital does not predict mortality for pancreatic resections. HPB Surg. 2008; 2008:190914.
  17. Jancelewicz T, Vu LT, Shawo AE, Yeh B, Gasper WJ, Harris HW. Predicting strangulated small bowel obstruction: an old problem revisited. J Gastrointest Surg. 2009 Jan; 13(1):93-9.
  18. Kattan OM, Kasravi FB, Elford EL, Schell MT, Harris HW. Apolipoprotein E-mediated immune regulation in sepsis. J Immunol. 2008 Jul 15; 181(2):1399-408.
  19. Maa J, Wachter RM, Gosnell JE, Harris HW. The future of general surgery. JAMA. 2008 Mar 5; 299(9):1015; author reply 1015-6.
  20. Somsouk M, Shergill AK, Grenert JP, Harris H, Cello JP, Shah JN. Actinomycosis mimicking a pancreatic head neoplasm diagnosed by EUS-guided FNA. Gastrointest Endosc. 2008 Jul; 68(1):186-7.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.